In contrast, no significant difference was observed in AKT mRNA expression among the experimental groups (KruskalWallis H = 5.947, p = 0.114
In the Flinders University study, of the 6954 women first prescribed GLP-1 receptor agonists during 2022, 90.5% did not have type 2 diabetes, suggesting that many were using the medication for weight loss
Bifari F, Manfrini R, Dei Cas M, et al
That is why a patient exploring semaglutide, tirzepatide, or retatrutide should think beyond the medication itself
As most side effects occur during dose escalation, it is important to increase the dosage slowly according to the dosing schedule
Retatrutide has shown greater average weight loss than Mounjaro in separate clinical trials, but it is not currently approved or available